Our Partners
We are grateful to our partners that have assisted us with funding and expertise.
University of New England
UNE is ranked #1 in NIH funding among Maine colleges and universities. In 2016, Professor Sri Mohan found the NOHA compound was a reliable indicator for the most aggressive types of breast cancer. Mohan and UNE received the first patent for the research in 2018, and it was licensed by SatyaDx.​
​
​
For more information on UNE:
Maine Cancer Foundation
Maine Cancer Foundation is dedicated to reducing cancer incidence and mortatlity rates in Maine. 100% of their funds are invested back into the Maine community.
MCF has financially supported some of the clinical trials for demonstrating the efficacy of NOHA.
​
Funding Partner since 2017
​
For more information on Maine Cancer Foundation:
MaineHealth
MaineHealth is the preeminent healthcare provider in the State of Maine and includes nine local hospital systems. MaineHealth's Bonfire Innovation fund has invested in Satya Dx.
Susan Meisfeldt, MD is a founder and CMO of Satya Dx as well as a medical oncologist at MaineHealth.
​
Funding Partner 2017 & 2025
Ongoing clinical partner​
Sandy Christman Foundation
Their mission is to make health care delivery and outcomes better in western Tanzania. In doing so we hope to make the world a better, healthier, and safer place. Our efforts will be directed at people in need and not limited by religion, nationality, geographic borders, or fear.
They have provided financial support for our clinical trials in Tanzania.
​
Funding Partner since 2022
​
More information on the Sandy Christman Foundation
Maine Technology Institute
MTI offers grants, loans, equity investments, and services to businesses, organizations, and entrepreneurs to support Maine’s innovation economy. MTI has provided financial support to Satya Dx in the form of both a seed grant and loan.
​
Funding Partner since 2017
​
For more information on MTI: